Management Team

Management Team

NewCardio has assembled an experienced and skilled management team which has proven their ability to create new products and build new enterprises.

Jess Jones, M.D. - Chief Executive Officer

Dr. Jones has been a member of the Company's Board of Directors since December 2008 . From 2006 to December 2010 Dr. Jones worked with Vision Capital Advisors, LLC in New York City as the Director of Healthcare Investing, analyzing investment opportunities in the biotechnology, pharmaceutical, medical technology, and medical services fields, and assisted companies in implementing their business plans. From 2001 to 2007, Dr. Jones attended Columbia College of Physicians & Surgeons in New York City , where he received his medical degree in May 2007 . Additionally, Dr. Jones earned a BA degree from the University of Utah in 2001 and an MBA from Columbia Business School in May 2007.

Greg Sadowski - Chief Operating Officer

Mr. Sadowski has served as Senior Vice President, Client Services for NewCardio since October 2008 . In that position, he has been responsible for preparing, delivering and supporting the NewCardio cardiovascular diagnostic technology solutions, including the Professional Services, Information Technology, Customer Care and Quality Assurance groups. From October 1997 to October 2008 , Mr. Sadowski worked with eResearchTechnology (eRT), where he served on the Executive Management Team as Senior VP of eRT's Electronic Patient Reported Outcomes (ePRO) business.

Executive Consultants

NewCardio's Executive consultants are intimately involved with day to day activities and are spending significant portion of their time working with the Company.

Vincent Renz

Vinnie has more than 26 years of experience in the information technology industry, specifically in the development and commercialization of technology products and services. He previous worked at ClinPhone, the world's leading Clinical Technology Organization which was acquired by PAREXEL International Corporation, a leading global biopharmaceutical services organization. At ClinPhone, Mr. Renz served as Chief Operating Officer. Previously, he worked for eResearchTechnology, Inc. as the Executive Vice President and Chief Technology Officer and played a key role in building eResearchTechnology's clinical technology business. Mr. Renz was also instrumental in developing the global business development and client services infrastructure to support the company's rapid growth and profitability. Mr. Renz earned an M.B.A. in Management Information Systems from Indiana University and a B.B.A. in Finance from the University of Notre Dame.

Samuel George, MD, FACC, JD - Senior Medical Consultant

Sam was formerly Director of Medical Affairs at CV Therapeutics, a cardiology faculty member and Director of the Cardiac Study Program at Duke University Medical Center, and an Established Investigator of the American Heart Association. He was also a biomedical patent attorney with Latham & Watkins LLP and is registered to practice before the U.S. Patent and Trademark Office. He holds M.D. from Washington University (St. Louis) and JD from Duke University.